Transthyretin Is a Key Regulator of Myoblast Differentiation

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Lee, Eun Ju ^a   Bhat, Abdul R ^a   Kamli, Majid Rasool ^a   Pokharel, Smritee ^a   Chun, Tahoon ^b   Lee, Yong Ho ^c   Nahm, Sang Seop ^d   Nam, Joo Hyun ^e   Hong, Seong Koo ^f   Yang, Bohsuk ^f   Chung, Ki Young ^f   Kim, Sang Hoon ^g   Choi, Inho ^a  

^a Yeungnam University   (South Korea)

^b Korea University   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Konkuk University   (South Korea)

^e Dongguk University College of Medicine   (South Korea)

^f National Institute of Animal Science   (South Korea)

^g Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; MYOGENIN; PREALBUMIN; STROMAL INTERACTION MOLECULE 1; THYROXINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAV1.1 GENE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE SILENCING; HORMONE TRANSPORT; MALE; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; ORAI1 GENE; PROTEIN EXPRESSION; SKELETAL MUSCLE; STIM1 GENE; TTR GENE; UPREGULATION;

ANIMALS; CALCIUM CHANNELS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION; MALE; MICE; MICE, INBRED C57BL; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOBLASTS; MYOGENIN; PREALBUMIN; UP-REGULATION;

EID: 84878076113     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063627     Document Type: Article

References (52)

1. Chargé SB, Rudnicki MA, (2004) Cellular and molecular regulation of muscle regeneration. Physiological Reviews 84: 209-238.
2. Pavlath GK, (2010) Spatial and functional restriction of regulatory molecules during mammalian myoblast fusion. Experimental Cell Research 316: 3067-3072.
3. Arnaudeau S, Holzer N, Konig S, Bader CR, Bernheim L, (2006) Calcium sources used by post-natal human myoblasts during initial differentiation J Cell Physiol. 208: 435-445.
4. Konig S, Hinard V, Arnaudeau S, Holzer N, Potter G, et al. (2004) Membrane hyperpolarization triggers myogenin and myocyte enhancer factor-2 expression during human myoblast differentiation. J Biol Chem 279: 28187-28196.
5. Konig S, Beguet A, Bader CR, Bernheim L, (2006) The calcineurin pathway links hyperpolarization (Kir2.1)-induced Ca2+ signals to human myoblast differentiation and fusion. Development 133: 3107-3114.
6. Le GF, Rudnicki MA, (2007) Skeletal muscle satellite cells and adult myogenesis. Curr Opin Cell Biol 19: 628-633.
7. Barnoy S, Glaser T, Kosower NS, (1997) Calpain and calpastatin in myoblast differentiation and fusion: effects of inhibitors. Biochim. Biophys Acta 1358: 181-188.
8. Friday BB, Mitchell PO, Kegley KM, Pavlath GK, (2003) Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD. Differentiation 71: 217-227.
9. Pavlath GK, Horsley V, (2003) Cell fusion in skeletal muscle central role of NFATC2 in regulating muscle cell size. Cell Cycle 2: 420-423.
10. O'Connor RS, Mills ST, Jones KA, Ho SN, Pavlath GK, (2007) A combinatorial role for NFAT5 in both myoblast migration and differentiation during skeletal muscle myogenesis. J Cell Sci 120: 149-159.
11. Kubo Y, (1991) Electrophysiological and immunohistochemical analysis of muscle differentiation in a mouse mesodermal stem cell line. J Physiol 443: 711-741.
12. Chemin J, Nargeot J, Lory P, (2002) Neuronal T-type alpha1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15cellline. J Neurosci. 22: 6856-6862.
13. Mariot P, Vanoverberghe K, Lalevee N, Rossier MF, Prevarskaya N, (2002) Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J Biol Chem 29: 10824-33.
14. Spitzer NC, Gu X, Olson E, (1994) Action potentials, calcium transients and the control of differentiation of excitable cells. Curr Opin Neurobiol 4: 70-77.
15. Bito H, Deisseroth K, Tsien RW, (1997) Ca2+-dependent regulation in neuronal gene expression. Curr Opin Neurobiol 7: 419-429.
16. Nicotera P, Orrenius S, (1998) The role of calcium in apoptosis. Cell Calcium 23: 173-80.
17. Marshall J, Dolan BM, Garcia EP, Sathe S, Tang X, et al. (2003) Calcium channel and NMDA receptor activities differentially regulate nuclear C/EBPbeta levels to control neuronal survival. Neuron 14: 625-39.
18. Weick JP, Groth RD, Isaksen AL, Mermelstein PG, (2003) Interaction with PDZ proteins are required for L-type calcium channels to activate cAMP response element-binding protein-dependent gene expression. J Neurosci 23: 3446-3456.
19. Grassi C, D'Ascenzo M, Torsello A, Martinotti G, Wolf F, et al. (2004) Effects of 50 Hz electromagnetic fields on voltagegated Ca2+ channels and their role in modulation of neuroendocrine cell proliferation and death. Cell Calcium 35: 307-315.
20. Toescu EC, Verkhratsky A, Landfield PW, (2004) Ca2+ regulation and gene expression in normal brain aging. Trends Neurosci 27: 614-620.
21. Catterall WA, (2011) Voltage-gated calcium channels. Cold Spring Harb Perspect Biol 3: a0003947.
22. Numaga TT, Putney JW (2012) Role of STIM1 and Orai1-mediated calcium J entry in Ca2+-induced epidermal keratinocyte differentiation. J Cell Sci doi: 10.1242/jcs.115980.
23. Baryshnikov SG, Pulina MV, Zulian A, Linde CI, Golovina VA, (2009) Orai1, a critical component of store-operated Ca2+ entry, is functionally associated with Na+/Ca2+ exchanger and plasma membrane Ca2+ pump in proliferating human arterial myocytes. Am J Physiol Cell Physiol 297: C1103-11012.
24. Samantha JR, (2007) Cell and Molecular Biology of Transthyretin and Thyroid Hormones. Int Rev Cytol 258: 137-193.
25. Johnson SM, Connelly S, Fearns C, Powers ET, Kelly JW, (2012) The transthyretinamyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug. J Mol Biol 10: 185-203.
26. Hamiltona JA, Bensonb MD, (2001) Transthyretin: a review from a structural perspective. CMLS, Cell. Mol Life Sci 58: 1491-1521.
27. Dianne RS, Joseph H, KennJeth S, Eric AS, DeWitt G, (1985) Demonstration of Transthyretin mRNA in the Brain and other Extrahepatic Tissues in the Rat. J Biol Chem 260: 11793-11798.
28. Nunes AF, Liz MA, Franquinho F, Teixeira L, Sousa V, et al. (2010) Neuropeptide Y expression and function during osteoblast differentiation-insights from transthyretin knockout mice. FEBS J 277: 263-75.
29. Smith KL, Herron B, Dowell MN, Wu H, Kim SJ, et al, (2012) Knockdown of cortical transthyretinexpression around implanted neural prosthetic devices using intraventricular siRNA injection in the brain. J Neurosci Methods 203: 398-406.
30. Lee EJ, Lee HJ, Kamli MR, Pokharel S, Bhat AR, Lee YH, et al. (2012) Depot-specific gene expression profiles during differentiation and transdifferentiation of bovine muscle satellite cells, and differentiation of preadipocytes. Genomics 100: 195-202.
31. Brigitle P, Frederic D, Yves G, (1998) Muscle Differentiation of Normal and Double-Muscled Bovine Foetal Myoblasts in Primary Culture. Basic Appl Myol 8: 197-203.
32. Veliça P, Bunce CM, (2012) A quick, simple and unbiased method to quantify C2C12 myogenic differentiation. Muscle Nerve 44: 366-370.
33. Bradford MM, (1976) Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
34. Lin HY, Davis FB, Luidens MK, Mousa SA, Cao JH, et al. (2011) Molecular basis for certain neuroprotective effects of thyroid hormone. Front Mol Neurosci 4: 29.
35. Monk JA, Sims NA, Dziegielewska KM, Weiss RE, Ramsay RG, et al. (2013) Delayed development of specific thyroid hormone-regulated events in transthyretin null mice. Am J Physiol Endocrinol Metab. 304: E23-31.
36. Molkentin JD, Olson EN, (1996) Defining the regulatory networks for muscle development. Curr Opin Gen Dev 6: 445-453.
37. Gayraud-Morel B, Chrétien F, Flamant P, Gomès D, Zammit PS, et al. (2007) A role for the myogenic determination gene Myf5 in adult regenerative myogenesis. Dev Biol 312: 13-28.
38. Darbellay B, Arnaudeau S, König S, Jousset H, Bader C, et al. (2009) STIM1- and Orai1-dependent store-operated calcium entry regulates human myoblast differentiation. 284: 5370-80.
39. Lyfenko AD, Dirksen RT, (2008) Differential dependence of store-operated and excitation-coupled Ca2+ entry in skeletal muscle on STIM1 and Orai1. J Physiol 586: 4815-24.
40. Stiber J, Hawkins A, Zhang ZS, Wang S, Burch J, et al. (2008) STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle. Nat Cell Biol 10: 688-97.
41. Kotturi MF, Carlow DA, Lee JC, Ziltener HJ, Jefferies WA, (2003) Identification and functional characterization of voltage-dependent calcium channels in T lymphocytes. J Biol Chem 278: 46949-60.
42. Kotturi MF, Jefferies WA, (2005) Molecular characterization of L-type calcium channel splice variants expressed in human T lymphocytes. Mol Immunol 42: 1461-74.
43. Andrés V, Walsh K, (1996) Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 132: 657-66.
44. Cognard C, Constantin B, Rivet-Bastide M, Imbert N, Besse C, et al. (1993) Appearance and evolution of calcium currents and contraction during the early post-fusional stages of rat skeletal muscle cells developing in primary culture. Development 117: 1153-61.
45. Hou X, Parkington HC, Coleman HA, Mechler A, Martin LL, et al. (2007) Transthyretin oligomers induce calcium influx via voltage-gated calcium channels. J Neurochem 100: 446-57.
46. Porter GA, Makuck RF, Rivkees SA, (2002) Reduction in intracellular calcium level inhibits myoblast differentiation. J Biol Chem 277: 28942-28947.
47. Liu JH, Bijlenga P, Occhiodoro T, Fischer-Lougheed J, Bader CR, et al. (1999) Mibefradil (Ro 40-5967) inhibits several Ca2+ and K+ currents in human fusion-competent myoblasts. Br J Pharmacol 126: 245-50.
48. Slotkin TA, Seidler FJ, Kavlock RJ, Bartolome JV, (1992) Thyroid hormone differentially regulates cellular development in neonatal rat heart and kidney. Teratology 45: 303-12.
49. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, et al. (2001) Plasma Membrane Transport of Thyroid Hormones and Its Role in Thyroid Hormone Metabolism and Bioavailability. Endocrine Reviews 22: 451-476.
50. Carnac G, Albagli-Curiel O, Desclozeaux M, Vandromme M, Glineur C, et al. (1993) Overexpression of c-erbA proto-oncogene enhances myogenic differentiation. Oncogene 8: 3103-10.
51. Rosen HN, Moses AC, Murrell JR, Liepnieks JJ, Benson MD, (1993) Thyroxine interactions with transthyretin: a comparison of 10 different naturally occurring human transthyretin variants. J Clin Endocrinol Metab77: 370-4.
52. Downes M, Griggs R, Atkins A, Olson EN, Muscat GE, (1993) Identification of a thyroid hormone response element in the mouse myogenin gene: characterization of the thyroid hormone and retinoid X receptor heterodimeric binding site. Cell Growth Differ 4: 901-9.